Please log in to view this page
Username
Password
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
